Selection of solid dosage form composition through drug-excipient compatibility testing

Journal of Pharmaceutical Sciences

Volumn 88, Issue 7, 1999, Pages 696-704

  Serajuddin, Abu T M ^a,c   Thakur, Ajit B ^c   Ghoshal, Rabin N ^c   Fakes, Michael G ^c   Ranadive, Sunanda A ^c   Morris, Kenneth R ^b,c   Varia, Sailesh A ^c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b PURDUE UNIVERSITY   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CERANAPRIL; EXCIPIENT; FOSINOPRIL; PRAVASTATIN; SORIVUDINE;

ARTICLE; DRUG DOSAGE FORM; DRUG SCREENING; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; LIGHT; MOISTURE; PH; TEMPERATURE;

EID: 0032809138     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980434g     Document Type: Article

References (29)

1. Monkhouse, D. C.; Maderich, A. Whither compatibility testing? Drug Dev. Ind. Pharm. 1989, 15, 2115-2130.
2. Monkhouse. D. C. Excipient compatibility possibilities and limitations in stability prediction. In Stability Testing in the EC, Japan and the USA: Scientific and Regulatory Requirements; Grimm, W., Krummen, A., Eds.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1993; pp 67-74.
3. Morris, K. R.; Newman, A. W.; Bugay, D. E.; Singh, A. K.; Ranadive, S. A.; Szyper, M.; Varia, S. A.; Brittain, H. G.; Serajuddin, A. T. M. Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development. Int. J. Pharm. 1994, 108, 195-206.
4. Carstensen, J. T. Drug Stability: Principles and Practices; Marcel Dekker: New York, 1990; pp 129-207.
5. Carstensen, J. T.; Gerhardt, A.; Morris, T.; Nikfar, F. Effect of moisture on solid dosage forms. Can the Arrhenius equation be used as a predictor? Drug Dev. Ind. Pharm. 1990, 16, 2267-2281.
6. Patel, N. K.; Patel, I. J.; Cutie, A. J.; Wadke, D. A.; Monkhouse, D. C.; Reier, G. E. The effect of selected direct compression excipient on the stability of aspirin as a model hydrolyzable drug. Drug Dev. Ind. Pharm. 1998, 14, 77-98.
7. Carstensen, J. T.; Johnson, J. B.; Valentine, W.; Vance, J. J. Extrapolation of appearance of tablets and powders from accelerated storage tests. J. Pharm. Sci. 1964, 53, 1050-1054.
8. van Dooren, A. A. Design for drug-excipient interaction studies. Drug Dev. Ind. Pharm. 1983, 9, 43-55.
9. Gu, L.; Strickley, R. G.; Chi, L. H.; Chowhan, Z. T. Drug-excipient incompatibility studies of the dipeptide angiotensin-converting enzyme inhibitor, moexipril hydrochloride: dry powder vs wet granulation. Pharm. Res. 1990, 7, 379-383.
10. Shalaev, E. Y.; Zografi, G.; How does residual water affect the solid-state degradation of drugs in the amorphous state? J. Pharm. Sci. 1996, 85, 1137-1141.
11. Zografi, G.; Kontny, M. J. The interactions of water with cellulose-and starch-derived pharmaceutical excipients. Pharm. Res. 1986, 3, 187-194.
12. Oksanen, C. A.; Zografi, G. Molecular mobility in mixtures of absorbed water and solid poly(vinylpyrrolidone). Pharm. Res. 1993, 10, 791-799.
13. Atwal, K. S.; Bergey, J. L.; Hedberg, A.; Moreland, S. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. J. Med. Chem. 1987, 30, 635-640.
14. Goodhart, F.; Middleton, K. R.; Chowhan, Z.; Jones, T. M. Lactose. In Handbook of Pharmaceutical Excipients; American Pharmaceutical Association: Washington, DC, 1986; pp 153-162.
15. Globitza, B. W.; Oelkrug, D.; Schmidt, P. C. Surface acidity of solid pharmaceutical excipients. 1: determination of surface acidity. Eur. J. Pharm. Biopharm. 1994, 40(5), 289-293.
16. Wirth, D. D.; Baertschi, S. W.; Johnson, R. A.; Maple, S. R.; Miller, M. S.; Hallenbeck, D. K.; Gregg, S. M. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. J. Pharm. Sci. 1998, 87, 31-39.
17. Thakur, A. B.; Morris, K.; Grosso, J. A.; Himes, K.; Thottathil, J. K.; Jerzewski, R. L.; Wadke, D. A.; Carstensen, J. T. Mechanism and kinetics of metal ion-mediated degradation of fosinopril sodium. Pharm. Res. 1993, 10, 800-809.
18. Joshi, Y. M.; Chiesa, P.; Jain, N. B. Pravastatin pharmaceutical composition having good stability. U. S. Patent 5, 180,-589, January 19, 1993.
19. Desai, D. S.; Abdelnasser, M. A.; Rubitski, B. A; Varia, S. A. Photostabilization of uncoated tablets of sorivudine and nifedipine by incorporating synthetic iron oxides. Int. J. Pharm. 1994, 103, 69-76.
20. Nikfar, F.; Ku, C.; Jerzewski, R.; Jain, N. Formulation development of BMS-180291-02: Effect of microenvironmental pH. Pharm. Res. 1994, 11 (Suppl.), S-166.
21. Thakur, A. B.; Chen, X.; Bugay, D. E.; Serajuddin, A. T. M. Solid state incompatibility of dicalcium phosphate dihydrate with the sodium salt of a poorly water-soluble drug. Pharm. Res. 1994, 11 (Suppl.), S-166.
22. Carstensen, J. T. Drug Stability: Principles and Practices. Marcel Dekker: New York, 1990; p 202.
23. Nikfar, F.; Serajuddin, A. T. M.; Jerzewski, R.; Jain, N. B. Pharmaceutical compositions having good dissolution properties. U.S. and European patents filed.
24. Wadke, D. A.; Serajuddin, A. T. M.; Jacobson, H. Preformulation testing. In Pharmaceutical Dosage Forms: Tablets; Lieberman, H. A., Lachman, L., Schwartz, J. B., Eds.; Marcel Dekker: New York, 1989; pp 1-73.
25. Hancock, B. C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997, 86, 1-12.
26. Morris, K. R.; Fakes, M. G.; Thakur, A. B.; Newman, A. W.; Singh, A. K.; Venit, J. J.; Spagnuolo, C. J.; Serajuddin, A. T. M. An integrated approach to the selection of optimal salt form for a new drug candidate. Int. J. Pharm. 1994, 105, 209-217.
27. Brandi, M.; Magill, A.; Rudraraju, V.; Gordon, M. S. Approaches for improving the stability of ketorolac in powder blends. J. Pharm. Sci. 1995, 84, 1151-1153.
28. Schildcrout, S. A.; Risley, D. S.; Kleemann, R. L. Drug-excipient interactions of seproxetine maleate hemihydrate: Isothermal stress methods. Drug Dev. Ind. Pharm. 1993, 19, 1113-1130.
29. Stahl, P. H. Characterization and improvement of the stability behavior of drug substances. In Stability Testing in the EC, Japan and the USA: Scientific and Regulatory Requirements; Grimm, W., Krummen, K., Eds.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 1993; pp 45-65.